This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Babylon Holdings Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

Babylon Holdings şirketinin toplam hissedar öz sermayesi $-315.1M ve toplam borcu $295.4M olup, bu da borç-öz sermaye oranını -93.8% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $208.0M ve $523.1M dir.

Anahtar bilgiler

-93.8%

Borç/özkaynak oranı

US$295.45m

Borç

Faiz karşılama oranı	n/a
Nakit	US$25.58m
Eşitlik	-US$315.06m
Toplam yükümlülükler	US$523.06m
Toplam varlıklar	US$207.99m

Son finansal sağlık güncellemeleri

Recent updates

Babylon to execute 1-for-25 reverse share split

Nov 09

Babylon Holdings files to sell 145.89M Class A ordinary shares

Oct 17

Babylon receives NYSE notice and gets approval for reverse share split at a consolidation ratio of between 15 and 25

Sep 22

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: BBLN.F negatif hissedar özkaynağı var; bu, kısa vadeli varlıkların kısa vadeli yükümlülükleri karşılamamasından daha ciddi bir durumdur.

Uzun Vadeli Yükümlülükler: BBLN.F şirketinin negatif özkaynağı bulunmaktadır; bu, kısa vadeli varlıkların uzun vadeli yükümlülükleri karşılamamasından daha ciddi bir durumdur.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: BBLN.F negatif hissedar özkaynağı var ki bu yüksek borç seviyesinden daha ciddi bir durumdur.

Borcun Azaltılması: BBLN.F 'in negatif özkaynağı var, dolayısıyla borcunun zaman içinde azalıp azalmadığını kontrol etmemize gerek yok.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: BBLN.F son raporlanan serbest nakit akışına göre 1 ay boyunca yeterli nakit pistine sahiptir, ancak o zamandan beri ek sermaye artırmıştır.

Tahmini Nakit Akışı: BBLN.F serbest nakit akışı tahminlerine göre 1 ay boyunca yeterli nakit akışına sahip olması öngörülüyor, ancak o zamandan beri ek sermaye artırdı.

This company listing is no longer active

Babylon Holdings Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Babylon Holdings Limited Filed for Bankruptcy

Babylon Announces the Receipt of Continued Listing Standards Notice from NYSE and Upcoming Delisting

Babylon Receives Share Price Notice from the New York Stock Exchange Due to Non-Compliance with NYSE Rule 802.01C

Recent updates

Babylon Holdings Limited Filed for Bankruptcy

Babylon Announces the Receipt of Continued Listing Standards Notice from NYSE and Upcoming Delisting

Babylon Holdings Limited Announces Board Changes

Babylon Holdings Limited announced that it expects to receive $34.5 million in funding from AlbaCore Capital LLP

First quarter 2023 earnings released: US$2.53 loss per share (vs US$5.94 loss in 1Q 2022)

Global Chief Medical Officer recently sold US$74k worth of stock

Global Chief Medical Officer recently sold US$74k worth of stock

Consensus revenue estimates decrease by 16%, EPS upgraded

Full year 2022 earnings: EPS exceeds analyst expectations

Babylon Holdings Limited to Report Q4, 2022 Results on Mar 09, 2023

Babylon Holdings Limited Provides Unaudited Earnings Guidance for the Year Ended December 31, 2022

Consensus estimates of losses per share improve by 10%

Price target decreased to US$2.10

High number of new and inexperienced directors

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

VNV (Cyprus) Limited Engages in Discussions with Babylon Holdings Limited

Babylon to execute 1-for-25 reverse share split

Babylon Holdings Limited announced that it has received $80 million in funding from VNV Global AB (publ), Kinnevik AB and other investors

Babylon Holdings Limited announced that it expects to receive $61.45 million in funding from VNV Global AB (publ), Kinnevik AB and other investors

Babylon Holdings Limited Announces Resignation of Yon Nuta as Chief Product Officer, Effective October 18, 2022

Babylon Holdings files to sell 145.89M Class A ordinary shares

Babylon Holdings Limited to Report Q3, 2022 Results on Nov 10, 2022

Babylon Holdings Reportedly to Sell Meritage IPA Assets in Early 2023

Babylon Hires Andrew Hine as Vice President of the Europe, Middle East, & Africa & Asia Go-To-Market Team

Babylon Receives Share Price Notice from the New York Stock Exchange Due to Non-Compliance with NYSE Rule 802.01C

Babylon receives NYSE notice and gets approval for reverse share split at a consolidation ratio of between 15 and 25

Babylon Holdings Limited Announces Chief Financial Officer Changes

Babylon gets new CFO

Babylon Holdings Denies Acquisition Rumors

Babylon Holdings jumps after report of potential sale process

Second quarter 2022 earnings: EPS misses analyst expectations

Babylon Holdings Limited Provides Guidance for the Twelve Months Ending December 31, 2022

Babylon Holdings Limited Announces Executive Changes

Babylon Holdings Limited, Annual General Meeting, Sep 14, 2022

Babylon Holdings Limited to Report Q2, 2022 Results on Aug 09, 2022

Babylon Holdings Limited Provides Earnings Guidance for the Year 2022

Babylon +2%, expects $100M savings per year

Consensus revenue estimates increase by 11%

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Babylon Holdings Limited Revises Revenue Guidance for the Year 2022

Price target decreased to US$7.30

High number of new and inexperienced directors

Babylon Holdings Limited to Report Q1, 2022 Results on May 12, 2022

Consensus forecasts updated

Full year 2021 earnings: Revenues in line with analyst expectations

No longer forecast to breakeven

Babylon Holdings Limited to Report Q4, 2021 Results on Mar 10, 2022

Babylon Holdings Limited Announces Resignation of Stacy Saal as Chief Operating Officer, Effective February 12, 2022

Babylon Holdings: A Virtual Value-Based Care Leader With Upside

Babylon Holdings Limited (NYSE:BBLN) acquired DayToDay Health.

Babylon Holdings Limited Increases Revenue Guidance for the Full-Year 2022

Forecast to breakeven in 2024

High number of new and inexperienced directors

Babylon Launches AI in Rwanda in Next Step Towards Digitising Healthcare in Rwanda

Third quarter 2021 earnings released: US$0.08 loss per share

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin